Atlas Trials

Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings

Clinical trial NCT06368479 · COMPLETED

Trial details

NCT number
NCT06368479
Sponsor
bioLytical Laboratories
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatitis BHepatitis B Infection
Start date
2024-03-19
Primary completion
2024-07-19
Enrollment
1400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.